Your look.
Your health. Our science.

Your look.
Your health. Our Science.

Your look.
Your health. Our Science.

Revolutionary Injectable Technology

RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.

RCH-01

RCH-01

FOR Regrowing Hair
RCS-01

RCS-01

FOR Rejuvenating Skin
RCT-01

RCT-01

FOR Repairing Tendons

DermaPrecise™

Next-Gen Dermal Injection Technology
Better Technology. Better Outcomes.
DermaPrecise™ is a next-generation dermal injector designed to provide an improved level of control and precision for intradermal (dermis) and subcutaneous (extracellular matrix & fat) injections.
More About DermaPrecise™
RepliCel Announces Material Patent Milestones in Key Markets
10 months ago Aug 04, 2022
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key...
DermaPreciseTM Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections
10 months ago Aug 02, 2022
Independent Testing Performed by Innovacell Demonstrates the DermaPreciseTM Control Leads to Unparalleled Post-Injection Cell Survival and...
RepliCel’s Manufacturing Inspected by Japan’s PMDA
10 months ago Jul 28, 2022
After over a year of pandemic-related delays, representatives of Japan’s PMDA, attended at the Company’s...
+ All News